357 related articles for article (PubMed ID: 27397617)
1. Safety and Efficacy of Doxorubicin Drug-Eluting Embolic Chemoembolization of Hepatocellular Carcinoma Supplied by Extrahepatic Collateral Arteries.
Lokken RP; Fidelman N; Kolli KP; Kerlan RK
J Vasc Interv Radiol; 2016 Nov; 27(11):1698-1704. PubMed ID: 27397617
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization with doxorubicin-eluting superabsorbent polymer microspheres in the treatment of hepatocellular carcinoma: midterm follow-up.
Dekervel J; van Malenstein H; Vandecaveye V; Nevens F; van Pelt J; Heye S; Laleman W; Van Steenbergen W; Vaninbroukx J; Verslype C; Maleux G
J Vasc Interv Radiol; 2014 Feb; 25(2):248-55.e1. PubMed ID: 24295569
[TBL] [Abstract][Full Text] [Related]
3. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization].
Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221
[TBL] [Abstract][Full Text] [Related]
4. Transarterial Chemoembolization with Small Drug-Eluting Beads in Patients with Hepatocellular Carcinoma: Experience from a Cohort of 421 Patients at an Italian Center.
Aliberti C; Carandina R; Lonardi S; Dadduzio V; Vitale A; Gringeri E; Zanus G; Cillo U
J Vasc Interv Radiol; 2017 Nov; 28(11):1495-1502. PubMed ID: 28927662
[TBL] [Abstract][Full Text] [Related]
5. Transarterial Chemoembolization Using 100-μm Drug-Eluting Microspheres in Patients with Hepatocellular Carcinoma: A Prospective Study and Midterm Follow-up.
Ou HY; Wu YN; Yu CY; Chen CL; Hsu HW; Weng CC; Leung-Chit Tsang L; Huang TL; Tong YS; Lim WX; Cheng YF
J Vasc Interv Radiol; 2020 Nov; 31(11):1784-1791. PubMed ID: 33023805
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma: usefulness of contrast saturation features on cone-beam computed tomography imaging for predicting short-term tumor response.
Suk Oh J; Jong Chun H; Gil Choi B; Giu Lee H
J Vasc Interv Radiol; 2013 Apr; 24(4):483-9. PubMed ID: 23452553
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of doxorubicin drug-eluting bead transarterial chemoembolization in patients with advanced hepatocellular carcinoma.
Prajapati HJ; Dhanasekaran R; El-Rayes BF; Kauh JS; Maithel SK; Chen Z; Kim HS
J Vasc Interv Radiol; 2013 Mar; 24(3):307-15. PubMed ID: 23375519
[TBL] [Abstract][Full Text] [Related]
8. Transarterial Chemoembolization of Hepatocellular Carcinoma Using Radiopaque Drug-Eluting Embolics: How to Pursue Periprocedural Cross-Sectional Imaging?
Ruff C; Grözinger G; Syha R; Elser S; Partovi S; Bitzer M; Horger M; Nikolaou K; Grosse U
J Vasc Interv Radiol; 2019 Mar; 30(3):380-389.e4. PubMed ID: 30819480
[TBL] [Abstract][Full Text] [Related]
9. Degradable starch microspheres versus ethiodol and doxorubicin in transarterial chemoembolization of hepatocellular carcinoma.
Niessen C; Unterpaintner E; Goessmann H; Schlitt HJ; Mueller-Schilling M; Wohlgemuth WA; Stroszczynski C; Wiggermann P
J Vasc Interv Radiol; 2014 Feb; 25(2):240-7. PubMed ID: 24291001
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes of Very Small Drug-Eluting Beads Used in Chemoembolization of Unresectable Hepatocellular Carcinoma.
Aal AKA; Moawad S; Lune PV; El Khudari H; Hanaoka MM; Abouldahab N; Gunn AJ; White J; Shoreibah M; Li Y; Saddekni S; Mahmoud K
J Vasc Interv Radiol; 2019 Sep; 30(9):1325-1334.e2. PubMed ID: 31371139
[TBL] [Abstract][Full Text] [Related]
11. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
[TBL] [Abstract][Full Text] [Related]
12. A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma.
Kucukay F; Badem S; Karan A; Ozdemir M; Okten RS; Ozbulbul NI; Kucukay MB; Unlu I; Bostanci EB; Akdogan M
J Vasc Interv Radiol; 2015 Nov; 26(11):1622-9. PubMed ID: 26321015
[TBL] [Abstract][Full Text] [Related]
13. The march of extrahepatic collaterals: analysis of blood supply to hepatocellular carcinoma located in the bare area of the liver after chemoembolization.
Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Matsui O
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):513-22. PubMed ID: 19756862
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factors.
Lee IJ; Chung JW; Kim HC; Yin YH; So YH; Jeon UB; Jae HJ; Cho BH; Park JH
J Vasc Interv Radiol; 2009 Jan; 20(1):22-9. PubMed ID: 19026566
[TBL] [Abstract][Full Text] [Related]
15. Korean Multicenter Registry of Transcatheter Arterial Chemoembolization with Drug-Eluting Embolic Agents for Nodular Hepatocellular Carcinomas: Six-Month Outcome Analysis.
Lee M; Chung JW; Lee KH; Won JY; Chun HJ; Lee HC; Kim JH; Lee IJ; Hur S; Kim HC; Kim YJ; Kim GM; Joo SM; Oh JS
J Vasc Interv Radiol; 2017 Apr; 28(4):502-512. PubMed ID: 27856136
[TBL] [Abstract][Full Text] [Related]
16. Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.
Pritchard WF; Woods DL; Esparza-Trujillo JA; Starost MF; Mauda-Havakuk M; Mikhail AS; Bakhutashvili I; Leonard S; Jones EC; Krishnasamy V; Karanian JW; Wood BJ
J Vasc Interv Radiol; 2020 May; 31(5):812-819.e1. PubMed ID: 32107125
[TBL] [Abstract][Full Text] [Related]
17. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization.
Miyayama S; Matsui O; Taki K; Minami T; Ryu Y; Ito C; Nakamura K; Inoue D; Notsumata K; Toya D; Tanaka N; Mitsui T
Cardiovasc Intervent Radiol; 2006; 29(1):39-48. PubMed ID: 16328697
[TBL] [Abstract][Full Text] [Related]
18. Chemoembolization of the left inferior phrenic artery in patients with hepatocellular carcinoma: radiographic findings and clinical outcome.
Suh SH; Won JY; Lee DY; Lee JT; Lee KH
J Vasc Interv Radiol; 2005 Dec; 16(12):1741-5. PubMed ID: 16371544
[TBL] [Abstract][Full Text] [Related]
19. Chemoembolization for hepatocellular carcinoma supplied by a lumbar artery.
Kim HM; Kim HC; Woo S; Son KR; Cho SW; Chung JW
Cardiovasc Intervent Radiol; 2015 Feb; 38(1):121-8. PubMed ID: 24849301
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Drug-Eluting Embolics versus Conventional Transarterial Chemoembolization for the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis.
Wu X; Chapiro J; Malhotra A; Kothary N
J Vasc Interv Radiol; 2021 Jan; 32(1):2-12.e1. PubMed ID: 33160827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
